Sunshine Biopharma Inc. (SBFM) Financials Nov 14,
Post# of 250675
Posted On: 11/17/2014 1:47:35 AM
Sunshine Biopharma Inc. (SBFM) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Sunshine Biopharma Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 0 0 0 0 0
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 0 0 0 0 0
Depreciation 0 0 0 0 0
Amortization of Intangibles 0 0 0 0 0
Gross Income 0 0 0 0 0
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 255,154 761 332,470 706,680 1.94M
Research & Development 0 0 142,650 1,829 137,400
Other SG&A 255,154 761 189,820 704,851 1.8M
Other Operating Expense 0 536,621 223,732 0 0
Unusual Expense 945,976 0 0 0 548,951
EBIT after Unusual Expense (945,976) 0 0 0 (548,951)
Non Operating Income/Expense 0 0 0 (1,272) 0
Non-Operating Interest Income - 0 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 0 0 0 0 6,455
Gross Interest Expense 0 0 0 0 6,455
Interest Capitalized 0 0 0 0 0
Pretax Income (1.2M) (537,382) (556,202) (707,952) (2.49M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 - 0 0
Consolidated Net Income (1.2M) (537,382) (556,202) (707,952) (2.49M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.2M) (537,382) (556,202) (707,952) (2.49M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.2M) (537,382) (556,202) (707,952) (2.49M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.2M) (537,382) (556,202) (707,952) (2.49M)
EPS (Basic) (0.05) (0.02) (0.02) (0.01) (0.04)
Basic Shares Outstanding 23.71M 29.86M 30.88M 49.78M 55.4M
EPS (Diluted) (0.05) (0.02) (0.02) (0.01) (0.04)
Diluted Shares Outstanding 23.71M 29.86M 30.88M 49.78M 55.4M
EBITDA (255,154) (537,382) (556,202) (706,680) (1.94M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Sunshine Biopharma Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 0 0 0 0 0
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 0 0 0 0 0
Depreciation 0 0 0 0 0
Amortization of Intangibles 0 0 0 0 0
Gross Income 0 0 0 0 0
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 255,154 761 332,470 706,680 1.94M
Research & Development 0 0 142,650 1,829 137,400
Other SG&A 255,154 761 189,820 704,851 1.8M
Other Operating Expense 0 536,621 223,732 0 0
Unusual Expense 945,976 0 0 0 548,951
EBIT after Unusual Expense (945,976) 0 0 0 (548,951)
Non Operating Income/Expense 0 0 0 (1,272) 0
Non-Operating Interest Income - 0 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 0 0 0 0 6,455
Gross Interest Expense 0 0 0 0 6,455
Interest Capitalized 0 0 0 0 0
Pretax Income (1.2M) (537,382) (556,202) (707,952) (2.49M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 - 0 0
Consolidated Net Income (1.2M) (537,382) (556,202) (707,952) (2.49M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.2M) (537,382) (556,202) (707,952) (2.49M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.2M) (537,382) (556,202) (707,952) (2.49M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.2M) (537,382) (556,202) (707,952) (2.49M)
EPS (Basic) (0.05) (0.02) (0.02) (0.01) (0.04)
Basic Shares Outstanding 23.71M 29.86M 30.88M 49.78M 55.4M
EPS (Diluted) (0.05) (0.02) (0.02) (0.01) (0.04)
Diluted Shares Outstanding 23.71M 29.86M 30.88M 49.78M 55.4M
EBITDA (255,154) (537,382) (556,202) (706,680) (1.94M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)